Non-Current Assets
Derivative Assets, Non-Current
Edwards Lifesciences Derivative Assets, Non-Current increased by 144.8% to $14.2M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 46.6%, from $26.6M to $14.2M. Over 2 years (FY 2023 to FY 2025), Derivative Assets, Non-Current shows a downward trend with a -50.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2023
Last reportedQ1 2026May 6, 2026
Metric ID:
derivative_assets_noncurrentHistorical Data
10 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.4M | $27.9M | $30.5M | $21.8M | $34.7M | $26.6M | $3.1M | $5.1M | $5.8M | $14.2M |
| QoQ Change | — | +19.2% | +9.3% | -28.5% | +59.2% | -23.3% | -88.3% | +64.5% | +13.7% | +144.8% |
| YoY Change | — | — | — | — | +48.3% | -4.7% | -89.8% | -76.6% | -83.3% | -46.6% |
Range$3.1M – $34.7M
CAGR-19.9%
Avg YoY Growth-42.1%
Median YoY Growth-61.6%
Current Streak3 quarters growth
Derivative Assets, Non-Current at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's derivative assets, non-current?
- Edwards Lifesciences (EW) reported derivative assets, non-current of $14.2M in Q1 2026.
- How has Edwards Lifesciences's derivative assets, non-current changed year-over-year?
- Edwards Lifesciences's derivative assets, non-current decreased by 46.6% year-over-year, from $26.6M to $14.2M.
- What is the long-term trend for Edwards Lifesciences's derivative assets, non-current?
- Over 2 years (2023 to 2025), Edwards Lifesciences's derivative assets, non-current has grown at a -50.2% compound annual growth rate (CAGR), from $23.4M to $5.8M.